(1)
Yu, X.; Liu, J.; Qiu, H.; Hao, H.; Zhu, J.; Peng, S. Combined Inhibition of ACK1 and AKT Shows Potential Toward Targeted Therapy Against KRAS-Mutant Non-Small-Cell Lung Cancer. Bosn J of Basic Med Sci 2021, 21, 198-207.